about
Tyrosine kinase inhibitors: friends or foe in treatment of hepatic fibrosis?Hepatotoxicity of targeted therapy for cancer.The role of damage associated molecular pattern molecules in acetaminophen-induced liver injury in mice.Intrinsic versus idiosyncratic drug-induced hepatotoxicity--two villains or one?Mechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria.Lactoferrin protects against acetaminophen-induced liver injury in mice.Influence of small doses of various drug vehicles on acetaminophen-induced liver injury.A challenge for diagnosing acute liver injury with concomitant/sequential exposure to multiple drugs: can causality assessment scales be utilized to identify the offending drug?High-content assays for hepatotoxicity using induced pluripotent stem cell-derived cellsLiver injury induced by high-dose methylprednisolone therapy: a case report and brief review of the literature.Acetaminophen-induced acute liver injury in HCV transgenic mice.Opportunities for use of human iPS cells in predictive toxicologyAn indole derivative protects against acetaminophen-induced liver injury by directly binding to N-acetyl-p-benzoquinone imine in mice.Acute hepatitis in a young woman with systemic lupus erythematosus: a diagnostic challenge.Pathogenic role of natural killer T and natural killer cells in acetaminophen-induced liver injury in mice is dependent on the presence of dimethyl sulfoxide.DAMPs ramp up drug toxicity.Determination of intracellular unbound concentrations and subcellular localization of drugs in rat sandwich-cultured hepatocytes compared with liver tissue.Ondansetron-induced aminotransferase level elevation: case report and review of the literature.Clinical syndromes and consequences of antiretroviral-related hepatotoxicity.Endoplasmic reticulum stress in drug- and environmental toxicant-induced liver toxicity.Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA Adverse Event Reporting System (FAERS) database.Methylprednisolone-induced liver injury: Case report and literature review.Acute liver damage following intravenous glucocorticoid treatment for Graves' ophthalmopathy.Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity.Drug metabolism and liver disease: a drug-gene-environment interaction.Hybrid in silico models for drug-induced liver injury using chemical descriptors and in vitro cell-imaging information.Chemical and in vitro biological information to predict mouse liver toxicity using recursive random forests.Imitation of drug metabolism in human liver and cytotoxicity assay using a microfluidic device coupled to mass spectrometric detection.Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity.miRNA-122 Protects Mice and Human Hepatocytes from Acetaminophen Toxicity by Regulating Cytochrome P450 Family 2 Subfamily A Member 2 and E Member 1 Expression.Acute ANIT toxicity in male IL-10 knockout and wild-type mice.Bacterial- and viral-induced inflammation increases sensitivity to acetaminophen hepatotoxicity.Characterization of hepatic mitochondrial injury induced by fatty acid oxidation inhibitors.Roles of lipoxin A4 in preventing paracetamol-induced acute hepatic injury in a rabbit model.Mixed learning algorithms and features ensemble in hepatotoxicity prediction.Using controlled clinical trials to learn more about acute drug-induced liver injury.Acetylcholinesterase Inhibitors for Alzheimer's Disease Treatment Ameliorate Acetaminophen-Induced Liver Injury in Mice via Central Cholinergic System Regulation.Autophagy in drug-induced liver toxicity.Establishment of a novel hepatocyte model that expresses four cytochrome P450 genes stably via mammalian-derived artificial chromosome for pharmacokinetics and toxicity studies.Natural polyphenol chlorogenic acid protects against acetaminophen-induced hepatotoxicity by activating ERK/Nrf2 antioxidative pathway.
P2860
Q28068710-B60FA7AC-8C5B-4F27-B4F4-FDCA6B692218Q30250288-2C5160EE-15FD-46FD-9354-359082303C9BQ33653566-E8C23EFA-8AB0-4354-8FD1-EB38D67F0A6BQ33714926-3264EEE7-F6BA-46E7-A46A-CB72B81C7B2CQ33954265-20DFFED0-36A2-4A11-BB7A-307E911AAEC3Q34013719-5EF2ACE6-31A4-408B-BB7B-9997E473A9D8Q34144857-84325DBD-DD49-4013-B1CC-7718EDDDE289Q34660447-BFCD9A97-BE6D-4C70-957D-4621F753B018Q35042726-216503B7-E7ED-4BDF-AE72-F674E25E2BBBQ35582456-C96788D2-5CCE-4C6D-8F52-4227DACE7A6CQ36501177-E783E4BB-6F58-4D25-8CBB-0E1D3BFD9F67Q36672246-56B56091-4523-450A-AE65-5E7E23013635Q36747189-D4598F03-C633-4EA4-8DF7-FDF4E980FBA7Q36820752-0B98E156-C139-4C5D-8CDB-773B191FD616Q36943218-39879C35-7F4D-4445-92A4-C37191DBC30BQ37073737-6A269BC4-642E-4687-B86F-D7AA7C2CE9B5Q37251993-1EE6C4E0-1EAA-4F58-A2B0-9E88FE505C2AQ37331789-73AA9CC0-3139-4C27-8E12-B25C77BBC101Q37784777-8B5CA1D7-B373-4BDA-B5E8-DDC5006E2808Q38193602-AA8D999F-6C8B-4C1C-BDE3-A64CE674B235Q38423805-1ADFBC93-A6F5-4324-A05F-A05DC1BE1CD8Q38671657-B9F65B50-84D9-4A81-819D-1B1CE9DC1D2AQ38784922-AF307A89-A05A-4C6E-9DA0-BB2ECE56B4FBQ38827021-1B9ADCA8-8C0F-406C-B191-3B7A006F45C5Q39037269-98897CF8-A9A9-4433-AC56-3630D39D2BCBQ39425631-EF1BCF32-9FDF-49EC-A003-9C0924755720Q39647931-882703FB-6CB8-4FB1-B17F-C0F7FCA7FE10Q39685824-9F133533-9B3B-426D-8447-FAEA213A5CE0Q41963390-801E8007-CFB9-4EE0-84FB-C1B916CB6207Q42516008-17A2C5B9-012F-4578-9FB3-94D953AD9546Q42975692-DC3F65B4-1E17-4F3E-9FC5-E81FFD038840Q43232351-6B6412A4-9BF9-4B2D-8618-B8BD9AF03D21Q44255490-C5F7A6B4-5A0B-4A82-8691-4B811940916CQ44625950-0C158AC5-206B-4978-AD7F-952EB1DC9208Q45372748-F36B9FFF-D19B-404D-B00B-F8995B623D1BQ45833400-FA5005B5-D44D-43A9-A8DA-CD20731D570CQ46477020-5412B1F7-DD1B-4922-8244-F496E013E37CQ47141835-941477CE-58F6-4DB7-B84D-FC498064779BQ47161371-90F3D3A3-8BB1-4CEE-B0AC-7DCEE489CC48Q47404871-4FB08609-79EB-4B94-967F-6AAC884AE8AB
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Mechanisms of drug-induced liver disease.
@en
type
label
Mechanisms of drug-induced liver disease.
@en
prefLabel
Mechanisms of drug-induced liver disease.
@en
P1476
Mechanisms of drug-induced liver disease.
@en
P2093
Basuki K Gunawan
Neil Kaplowitz
P304
P356
10.1016/J.CLD.2007.06.001
P577
2007-08-01T00:00:00Z